Chemomab Therapeutics Ltd. American Depositary Share (CMMB)
CMMB trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.24
-10.79% on the day
Market cap
$9.0M
Nano cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | CMMB on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Israel |
| IPO year | 2019 |
| SEC CIK | 0001534248 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | L3 |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | DRS | 2026-08-12 |
| Latest annual report | 20-F | 2026-03-23 |
| Latest quarterly / interim | 6-K | 2026-09-30 |
| Latest current report | 8-K | 2023-06-16 |
| Latest proxy | DEFA14A | 2022-05-31 |
Source: SEC EDGAR submissions feed, 360 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MBRX | Moleculin Biotech Inc. | $0.4352 | +5.15% | $8.9M |
| ADIL | Adial Pharmaceuticals Inc | $3.29 | -6.00% | $8.6M |
| MTVA | MetaVia Inc. | $1.43 | -1.38% | $9.4M |
| VTGN | Vistagen Therapeutics Inc. | $0.2148 | -5.21% | $9.5M |
| IMRN | Immuron Limited | $1.04 | 0.00% | $8.4M |
| KPTI | Karyopharm Therapeutics Inc. | $0.4274 | -15.38% | $9.7M |
| BOLT | Bolt Biotherapeutics Inc. | $4.29 | +1.06% | $8.3M |
| TOVX | Theriva Biologics Inc. | $0.2157 | -1.69% | $9.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier